April 2012

Chief Medical Editor's Page

New Insights Into the Vitreous and Choroid

Allen C. Ho, MD, and Robert L. Avery, MD

Letters

Novel Optogenetic Therapy May Restore Vision After Retinal Degeneration

Researchers have developed an approach to restore vision using a component of green algae.

Callan Navitsky, Associate Editor

Health Care Reform 2012

Significant changes are expected in coming years.

George A. Williams, MD

Clinical Endpoints for Retinal Disorders

Aron Shapiro and Ashley Lafond

Transitioning From a Fellow to an Attending

David Barañano, MD, PhD; Leon Charkoudian, MD; Jorge Fortun, MD; Rahul Khurana, MD; and Jeremy Wolfe, MD

Vitreoretinal Surgery Without the Aid of an Ophthalmic Surgical Assistant

Strategies for performing independent surgery of the vitreous and retina.

Yannek I. Leiderman, MD, PhD

Intravitreal Bevacizumab for Vitreous Hemorrhage Secondary to PDR

Andres Amaya Espinosa, MD; Gina Baron Mendoza, MD; Maria Alejandra Toro Millan, MD; and Natalia Camacho Espinosa, MD

Surgical Management of Massive Submacular Hemorrhage

Vitrectomy and subretinal rtPA are options to be considered.

Gene W. Chen, MD, and Andrew A. Moshfeghi, MD, MBA

Choroidal Hemangioma Masquerading as Central Serous Chorioretinopathy

Yasmin Poustchi, BA; Swathi Kaliki, MD; and Carol L. Shields, MD

A New Focus on the Vitreous and Its Role in Retinal Function

Pravin U. Dugel, MD

Treatment of Vitreomacular Adhesion: Present Status, Future Prospects

The technology is already in use for diagnosis and management of some conditions.

J. Sebag, MD, FACS, FRCOphth, FARVO

Choroidal Imaging Offers a New Window on Disease Management

Enhanced depth SD-OCT imaging opens a new frontier in understanding of the choroid.

Peter K. Kaiser, MD

Choroid Study Defines Normal Ranges of Variation

Bruno Lumbroso, MD

Limbus-based Vitrectomy Offers Safe Alternative in Pediatric Cases

Corneal entry site in aphakic eyes avoids risks of more posterior access.

Vinit B. Mahajan, MD, PhD

Multicolor Scan Laser Photocoagulator Provides Efficiencies in the Clinic

The MC-500 Vixi laser is capable of any combination of red, green, and yellow wavelengths.

Evangelia Papavasileiou, MD, FEBOphth, and Som Prasad MS, FRCSEd, FRCOphth, FACS

AMD as an Inflammatory Disease

An understanding of the role of the immune system in AMD may lead to new therapeutic approaches.

Victor L. Perez, MD

Biologic Therapy for Posterior Uveitis and Panuveitis

Sirichai Pasadhika, MD; Eric B. Suhler, MD, MPH; and Emmett T. Cunningham, Jr., MD, PhD, MPH

5 Q With David F. Williams, MD, MBA

Dr. Williams is a Partner at VitreoRetinal Surgery, PA, and an Assistant Clinical Professor of Ophthalmology at the University of Minnesota.